Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758907
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening SystemCenExelEnrolling By InvitationNot Applicable
NCT07758907Enrolling By Invitation
Not Applicable
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Scr...CenExel
NCT07758621
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCCCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 3
NCT07758621Not Yet Recruiting
Phase 3
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Me...CSPC Megalith Biopharmace...
NCT07757867
Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia AreataTanta UniversityCompletedNot Applicable
NCT07757867Completed
Not Applicable
Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Are...Tanta University
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07758023
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEFAbbottNot Yet RecruitingNot Applicable
NCT07758023Not Yet Recruiting
Not Applicable
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mi...Abbott
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07757165
The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion TherapyFudan UniversityRecruitingPhase 2
NCT07757165Recruiting
Phase 2
The Necessity of Surgery in Patients With mGC Achieving Radiological Response Af...Fudan University
NCT07758257
Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions - Phase 2 (EspertaMente)Dr. Franco MolteniCompletedNot Applicable
NCT07758257Completed
Not Applicable
Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions -...Dr. Franco Molteni
NCT07757282
Peripheral Blood Lipidomic and Ceramide Profiles in Atrial FibrillationFirst Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
NCT07757282Recruiting
—
Peripheral Blood Lipidomic and Ceramide Profiles in Atrial FibrillationFirst Affiliated Hospital...
NCT07758868
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City HospitalNot Yet Recruiting
NCT07758868Not Yet Recruiting
—
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City Hospita...
NCT07757074
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reconstruction Post-MastectomyDu ZhengguiNot Yet Recruiting
NCT07757074Not Yet Recruiting
—
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reco...Du Zhenggui
NCT07757555
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia InternationalNot Yet RecruitingEarly Phase 1
NCT07757555Not Yet Recruiting
Early Phase 1
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia Internationa...
NCT07758309
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized StudiesCanadian HeritageCompletedNot Applicable
NCT07758309Completed
Not Applicable
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misi...Canadian Heritage
NCT07758595
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's DiseaseDenali Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07758595Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921...Denali Therapeutics Inc.
NCT07756671
Photodynamic Therapy For OnychomycosisThe University of Texas Health Science Center, HoustonNot Yet RecruitingPhase 1
NCT07756671Not Yet Recruiting
Phase 1
Photodynamic Therapy For OnychomycosisThe University of Texas H...
NCT07758998
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing StudentsMeral Feratoğlu ResearchNot Yet RecruitingNot Applicable
NCT07758998Not Yet Recruiting
Not Applicable
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Studen...Meral Feratoğlu Research
NCT07758101
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative ColitisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 1
NCT07758101Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and i...Guangdong Hengrui Pharmac...
NCT07758504
Comparison of Performing V-Notes Hysterectomy Under Spinal Anesthesia and General AnesthesiaCukurova UniversityNot Yet RecruitingNot Applicable
NCT07758504Not Yet Recruiting
Not Applicable
Comparison of Performing V-Notes Hysterectomy Under Spinal Anesthesia and Genera...Cukurova University
NCT07758075
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07758075Not Yet Recruiting
Phase 2
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Inject...Guangdong Hengrui Pharmac...
NCT07757217
Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's DiseaseShanghai 10th People's HospitalCompleted
NCT07757217Completed
—
Artificial Intelligence-Based Classification and Prognostic Prediction in Small...Shanghai 10th People's Ho...
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting3 (15%)
Enrolling by invitation1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 14 (20%)
Phase 22 (10%)
Phase 31 (5%)
Early Phase 11 (5%)